Decreased intraocular inflammation observed in MAPLE wet AMD study of abicipar April 3, 2019 No Comments
ALK-4290 demonstrates safety and improvement in BCVA score in patients with nAMD March 27, 2019 No Comments
Phase III ALLEVIATE study of reproxalap meets the primary and key secondary endpoint March 27, 2019 No Comments
TIME-2b study of AKB-9778 in diabetic retinopathy does not meet primary endpoint March 19, 2019 No Comments
SunRegen Healthcare presents data on SRG-003 in monkeys with optic atrophy March 19, 2019 No Comments
RSS